BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Endotis Pharma 

102 Route de Noisy
Parc Biotech
Romainville    93230  France
Phone: 33-1-48-464391 Fax: 33-1-48-469829


SEARCH JOBS










 Company News
Endotis Pharma Intiates Phase IIa Study of First-in-Class Neutralizable Anticoagulant in Open-Heart Surgery 6/22/2011 9:11:04 AM
Endotis Pharma Reports Successful Completion of the Neutralization Study of the Anticoagulant EP217609 by Avidin in Healthy Subjects 11/15/2010 1:20:51 PM
Endotis Pharma Presents Data on the Neutralizable Anticoagulant EP217609 and Its Specific Antidote Avidin in an Extracorporeal Circulation Model 9/13/2010 2:45:56 PM
Endotis Pharma Presents Phase I Clinical Trial Results For A First-In-Class Synthetic Parenteral Neutralizable Anticoagulant EP217609 At The 21st International Congress On Thrombosis 7/8/2010 11:57:42 AM
Endotis Pharma Presents Data On The Neutralizable Anticoagulant EP217609 In An Extracorporeal Circulation Model 6/4/2010 2:43:32 PM
Endotis Pharma Reports The Successful Completion Of Phase I Clinical Trials Of The Neutralizable Anticoagulant EP217609 And Its Antidote Avidin Under Development For Use In Heart Surgery 4/30/2010 1:45:23 PM
Endotis Pharma EP80061 Small-Glyco Drug To Be Presented At The American Association for Cancer Research Meeting In Washington DC, April 17th To 21st, 2010 4/16/2010 3:21:48 PM
Endotis Pharma Presents Phase I Clinical Trials Results for EP42675, a First-in-Class Synthetic Parenteral Anticoagulant 12/4/2009 10:18:50 AM
Catalent Pharma Solutions Enters a Strategic Alliance with Endotis Pharma 11/5/2009 10:10:00 AM
Endotis Pharma Reports Successful Completion of Phase I Program with EP42675, a First in Class Synthetic Parenteral Anticoagulant 5/19/2009 10:49:53 AM
12